Skip to content
Search
AI Powered
Latest Stories
Submit Guest Post

Weight loss drugs displace £1bn from Britain’s grocery bill

weight loss drugs

The growing use of weight loss drugs is reshaping Britain's grocery market, with £1bn displaced from grocery spending.

iStock image
  • The impact of GLP-1 drugs on grocery spend has now surpassed £1 billion, up from £780 million in June.
  • The number of British households with a GLP-1 user has risen from 6.3% in February this year to 8.5% in August, or 2.6 million adults.
  • GLP-1 users are now found in as many British households as vegetarians and pescatarians combined.
  • Despite recent approval, pills now account for 11.2% of GLP-1 users, or more than one in ten, while men now make up 32% of users, up from 23% in February.

The number of British households with a GLP-1 drug user has risen from 6.3% in February this year to 8.5% in August, shows latest research, suggesting 2.6 million adults in Great Britain are using weight loss medication.

At 8.5%, GLP-1 users are now found in as many British households as vegetarians and pescatarians combined. This is also a similar proportion to the number of households buying Corona beer (8.4%) or Kellogg’s Rice Krispies (8.6%).


Worldpanel by Numerator has been studying the effect of these drugs on purchasing behaviour since March 2024. In its fourth wave of data, the findings draw from a total sample 9,629 households.

Despite only receiving recent approval from the Medicines and Healthcare products Regulatory Agency (MHRA) in June 2026, pills now account for 11.2% of GLP-1 users, or more than one in ten. Men are also driving growth, making up 32% of users, up from 23% in February. That equates to a near doubling of male users at 830,000 men, up from 440,000 in February.

Nishita Pattni, Senior Consultant at Worldpanel by Numerator, said: “GLP-1 users are now found in as many British homes as some of Great Britain’s best-known food and drink brands, and growth is accelerating.

"In just six months, between February and August 2026, user numbers rose almost as much as they did in the whole of the previous year. For many people, a daily pill is far easier than an injection, and with the surge in male users, we only expect the appeal of these drugs to grow.”

Displaced spend from Britain’s grocery market surpasses £1 billion

The impact of GLP-1 drugs on grocery spend has now surpassed £1 billion, up from £780 million in June, with 415 million fewer packs bought. That is equivalent to £389 a year displaced from user households’ shopping baskets.

But this isn’t simply a story of shoppers buying less. Spend and volume are falling at a similar rate overall, yet users’ habits are creating winners and losers across categories as they evolve.

Products often associated with impulse and indulgence purchases are taking the biggest hit. Alcohol spend among users has fallen 15% more than in non-user households, and spend on crisps has fallen 15%, one of the clearest signs of reduced impulse consumption as users snack less.

In contrast, easy, portion-controlled options are gaining ground. Frozen ready meals have seen a 30% uplift in volume, while a more unexpected winner is hot chocolate and malt drinks, up 22% in spend and 16% in volume. While ‘treating’ among users may be in decline, this points to the continued appeal of some small, easy-to-digest, everyday comforts.

Beyond the grocery aisle, some of the displaced money is going to health and beauty. GLP-1 users spent £78 million more than expected on health and beauty products in the first year after adoption, and 30% said they had spent more on clothing and footwear.

Chantel Kennaugh, Head of Public Sector and Nutrition at Worldpanel by Numerator said: “Too often, the GLP-1 impact is framed as a story about value or volume decline, but there’s a much more interesting story sitting behind this.

"From a grocery perspective, this new audience is being more mindful about what and how they eat. The key for retailers is how to support them, without isolating them. This might be as simple as producing clear labels that highlight nutrients like high protein or ensuring ranges are available in smaller portions sizes.

“Our estimates suggest that GLP-1 usage is set to surpass 10% of GB households in 2027. This is not a flash-in-the-pan trend, but a seismic change that requires retailers and manufacturers to re-think their strategies.”